|
GGC |
Interim MD&A - March 31, 2024 |
MD&A (Management Discussion and Analysis) |
15/05/2024 |
 Open Filing (270.86 KB) |
|
GGC |
Interim Financial Statements - March 31, 2024 |
Interim Financial Statements |
15/05/2024 |
Open Filing (278.91 KB) |
|
DRUG |
Bright Minds Biosciences - Interim MD&A |
MD&A (Management Discussion and Analysis) |
15/05/2024 |
Open Filing (871.14 KB) |
|
DRUG |
Bright Minds Biosciences - Interim Financial Statements |
Interim Financial Statements |
15/05/2024 |
Open Filing (453.58 KB) |
|
GHG |
Quarterly Listing Statement DECEMBER 31, 2023 |
Quarterly Listing Statement |
15/05/2024 |
Open Filing (613.08 KB) |
|
CL |
CSE Form 5 CL Q1 2024 |
Listing Statement |
15/05/2024 |
Open Filing (1.46 MB) |
|
CL |
Interim MD&A March 31, 2024 |
MD&A (Management Discussion and Analysis) |
15/05/2024 |
Open Filing (242.59 KB) |
|
CL |
Interim Financial Statements March 31, 2024 |
Interim Financial Statements |
15/05/2024 |
Open Filing (429.34 KB) |
|
GHG |
Form_5A_-_Annual_Summary_May 15, 2024 |
Annual Summary |
15/05/2024 |
Open Filing (1.29 MB) |
|
ETI |
Confirmation of Proceeds |
Other |
15/05/2024 |
Open Filing (135.98 KB) |
